Previous studies demonstrated that lenalidomide reduces the expression of PD-1 on natural killer (NK) cells, helper cells, and CTLs, and inhibits PD-L1 expression on tumor cells and myeloid-derived suppressor cells (MDSCs) in patients with MM (20, 34). The gene discussed is CD274; the disease is Miyoshi myopathy.